“publications”): www.doorway.ru Should any pertinent provisions of the law or regulations be modified in the future, DEA will issue a revised electronic version of this document, which will be published on the DEA Diversion Website. If you encounter errors in this document, please notify: Editor, DEA Practitioner’s Manual. Pharmacist FAQs. Frequently Asked Questions for Pharmacists on DEA Practitioner's Manaul. Q: How can I access the latest edition of the DEA's Practitioner's Manual? (www.doorway.ru) only. Search for this: Initiatives Federal Agencies Related Links Federal Register Notices National Prescription Drug Take Back Day NFLIS Publications Manuals Questions Answers Significant Guidance Documents Synthetic Drugs Title 21 , Registration and Program Support Section, Office of Diversion.
FOR FURTHER INFORMATION CONTACT: G. Thomas Gitchel, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC , telephone () SUPPLEMENTARY INFORMATION: A notice of proposed rulemaking was published in the Federal Register on Septem (58 FR ). license to practice medicine, be a registrant of the Drug Enforcement Administration (DEA), have the capacity to refer patients for appropriate counseling and other necessary ancillary services, and have completed required training. The CSA also imposes a limit on the number of patients a practitioner may treat with certain types of FDA-. Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier. · Chapter 1, “Prescriptive Authority” (pp. 1–3) · Chapter 2, “Rational Drug Selection and Prescription Writing” (pp. 5–9) · Chapter 3, “Promoting Positive Outcomes of Drug Therapy” (pp. 11–16).
9 окт. г. Section 5: Take-Back Events. Section 6: Storage of Collected www.doorway.ru On July 7, , Loren Miller, Associate Section Chief, Liaison and Policy site at www.doorway.ru Practitioners must know and comply with federal and state laws and included on its website: www.doorway.ruersion. www.doorway.ru
0コメント